Nymox Pharmaceutical  {NASDAQ: NYMX} director James Robinson purchased 40,000 shares on Thursday 24th March according to a filing report.

Robinson, purchased at an average price of $2.29.

Nymox Pharmaceutical Corporation {NASDAQ: NYMX} Director James George Robinson bought 40,000 shares of the business’s stock in a transaction on Thursday, March 24th.

The shares were acquired at an average cost of $2.29 per share, for a total transaction of $91,600.00.

Following the purchase, the director now directly owns 2,659,050 shares in the company, valued at $6,089,224.50.

The acquisition was disclosed in a legal filing with the SEC.